SMShilpi S. Mehta-Lee

Shilpi S. Mehta-Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shilpi S. Mehta-Lee has a total of 169 co-authors. Here are the top co-authors by number of shared publications:

  • Leonardo Trasande

    Department of Pediatrics, NYU Grossman School of Medicine, New York, USA

    7 shared publications
  • Linda Gross Kahn

    Department of Pediatrics, New York University Grossman School of Medicine, New York, NY, USA; Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA

    6 shared publications
  • Sara G. Brubaker

    Department of Obstetrics and Gynecology, New York University Langone Health/NYU Grossman School of Medicine, New York, USA

    6 shared publications
  • Jill P. Buyon

    Division of Rheumatology, New York University School of Medicine

    5 shared publications
  • Akhgar Ghassabian

    Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States; Departments of Pediatrics, New York University Grossman School of Medicine, New York, NY, United States

    4 shared publications
  • Kurunthachalam Kannan

    Department of Pediatrics, NYU Grossman School of Medicine, New York, USA

    4 shared publications

Latest Publications

  • Racial and ethnic disparities in environmental chemical exposures and hypertensive disorders of pregnancy: The ECHO-wide cohort study

    by Hongxiu Liu, Amii M Kress, Emma X Yu, Xuejuan Ning, Akhgar Ghassabian, Linda G Kahn, Shilpi Mehta-Lee, Sara Brubaker, Akram Alshawabkeh, John Meeker, et al.


  • Open Access

    Oxidative stress and fetal weight: observational findings from a pregnancy cohort in New York City

    by Carol Duh-Leong, Akhgar Ghassabian, Whitney Cowell, Sarvenaz Shahin, Mengling Liu, Kurunthachalam Kannan, Kristyn A. Pierce, Shilpi S. Mehta-Lee, Sara E. Long, Yuyan Wang, et al.

    Objective To examine associations between oxidative stress and fetal weight across pregnancy. Study design Cohort study of pregnant participants from 2016-2021 in New York City with urinary lipid, protein, and DNA oxidative stress biomarkers (25 weeks) and estimated fetal weight from ultrasound fetal biometry with the HadlockIII formula (20, 30, 36 weeks). Result Among 1408 participants, oxidative stress biomarkers of lipid peroxidation and DNA damage were associated with smaller estimated fetal weight at 30 and 36 weeks (ranging from B = –3.9 grams/unit increase [95% CI: –6.9, –0.9; 8,15 − PGF2α] to –20.3 [95% CI: –27.9, –12.8; 8 − OHdG]), particularly among fetuses at the 25th percentile. Oxidative stress biomarkers of protein damage were associated with larger estimated fetal weight at 20 (3.4 [95% CI: 1.2, 5.7]) and 36 weeks (16.5 [95% CI: 5.2, 27.8]). Conclusion These findings advance our understanding of different oxidative stress pathways and their potential role in fetal growth.


  • Using electronic health record data to identify incident uterine fibroids and endometriosis within a large, urban academic medical center: a validation study

    by Mia Charifson, Geidily Beaton-Mata, Robyn Lipschultz, India Robinson, Simone A Sasse, Hye-Chun Hur, Shilpi-Mehta S Lee, Erinn M Hade, Linda G Kahn

    Electronic health records (EHRs) present opportunities to study uterine fibroids and endometriosis within diverse populations. When using EHR data, it is important to validate outcome classification via diagnosis codes. We performed a validation study of 3 approaches ([1] International Classification of Diseases-10 (ICD-10) code alone, [2] ICD-10 code + diagnostic procedure, and [3] ICD-10 code + all diagnostic information) to identify incident uterine fibroids and endometriosis patients among n = 750 NYU Langone Health 2016-2023. Chart review was used to determine the true diagnosis status. When using a binary classification system (incident vs nonincident patient), Approaches 2 and 3 had higher positive predictive values (PPVs) for uterine fibroids (0.86 and 0.87 vs 0.78) and for endometriosis (0.70 and 0.73 vs 0.66), but Approach 1 outperformed the other 2 in negative predictive values (NPVs) for both outcomes. When using a 3-level classification system (incident vs prevalent vs disease-free patients), PPV for prevalent patients was low for all approaches, while PPV/NPV of disease-free patients was generally above 0.8. Using ICD-10 codes alone yielded higher NPVs but resulted in lower PPVs compared with the other approaches. Continued validation of uterine fibroids/endometriosis EHR studies is warranted to increase research into these understudied gynecologic conditions.


  • Prenatal exposure to residential greenness, fetal growth, and birth outcomes: a cohort study in New York City

    by Seulkee Heo, Yelena Afanasyeva, Mengling Liu, Shilpi Mehta-Lee, Wenqing Yang, Leonardo Trasande, Michelle L Bell, Akhgar Ghassabian

    Findings for greenspace’s impacts on birth outcomes are largely dependent on vegetation indexes. Examinations are needed for various greenspace indicators given varying pathways for fetal development. This prospective cohort study assessed the impacts of prenatal greenspace exposure on preterm birth (PTB), term low birthweight (TLBW), birthweight, and estimated fetal weight (EFW) for pregnant women in the New York City area, 2016-2023 (n = 2765). Longitudinal greenspace exposure was measured for residential histories during pregnancy using the enhanced vegetation index for 1000 m buffers and four park metrics, namely, the total number, sum of area, and the accessibility of parks within residential buffers (500 m) and the distance to the closest park. Multivariable regression models were used to estimate the associations for quartiles of exposure (with the first quartile [Q1] as reference). Greenspace exposure was not associated with TLBW, birthweight, or EFW. Odds ratios of PTB for the Q2, Q3, and Q4 enhanced vegetation index exposure groups compared to the Q1 group were 0.65 (95% CI, 0.43-0.98), 0.51 (95% CI, 0.32-0.80), and 0.56 (95% CI, 0.35-0.90), respectively. Preterm birth risks decreased in higher exposure groups (Q2-Q4) of the total park number. Results indicate the benefits of prenatal greenspace exposure for fetal maturity and neonatal outcomes.


  • Prenatal organophosphate pesticide exposure and sex-specific estimated fetal size

    by Eleanor A Medley, Leonardo Trasande, Mrudula Naidu, Yuyan Wang, Akhgar Ghassabian, Linda G Kahn, Sara Long, Yelena Afanasyeva, Mengling Liu, Kurunthachalam Kannan, et al.

    Prenatal organophosphate (OP) pesticide exposure may be associated with reduced fetal growth, although studies are limited and have mixed results. We investigated associations between prenatal OP pesticide exposure and fetal size and modification by fetal sex. Maternal urinary concentrations of dialkyl phosphate (DAP) metabolites were measured at 3 time points. Fetal biometrics were obtained from ultrasounds in the second (n = 773) and third (n = 535) trimesters. Associations between pregnancy-averaged ΣDAP and fetal biometry z scores were determined through multiple linear regression. Modification by sex was investigated through stratification and interaction. In the second trimester, one ln-unit increase in ΣDAP was associated with lower estimated fetal weight (–0.15 SD; 95% CI, –0.29 to –0.01), head circumference (–0.11 SD; CI, –0.22 to 0.01), biparietal diameter (–0.14 SD; CI, –0.27 to –0.01), and abdominal circumference (–0.12 SD; CI, –0.26 to 0.01) in females. In the third trimester, one ln-unit increase in ΣDAP was associated with lower head circumference (–0.14 SD; CI, –0.28 to 0.00) and biparietal diameter (–0.12 SD; CI, –0.26 to 0.03) in males. Our results suggest that prenatal OP pesticide exposure is negatively associated with fetal growth in a sex-specific manner, with associations present for females in mid-gestation and males in late gestation. This article is part of a Special Collection on Environmental Epidemiology.


  • Evaluating associations of bisphenol and phthalate exposure with time to pregnancy and subfecundity in a New York City pregnancy cohort

    by Mia Charifson, Eunsil Seok, Yuyan Wang, Shilpi S. Mehta-Lee, Rachel Gordon, Mengling Liu, Leonardo Trasande, Linda G. Kahn


  • Open Access

    Urinary concentrations of phthalate metabolites in relation to preeclampsia and other hypertensive disorders of pregnancy in the environmental influences on child health outcomes (ECHO) program

    by John D. Meeker, Kristen L. McArthur, Jennifer J. Adibi, Akram N. Alshawabkeh, Emily S. Barrett, Sara G. Brubaker, Jose F. Cordero, Dana Dabelea, Anne L. Dunlop, Julie B. Herbstman, et al.


  • The Association between Psychosocial Stressors and Gestational Weight Gain: Analysis of the National Pregnancy Risk Assessment Monitoring System (PRAMS) Results from 2012 to 2015

    by Shilpi S. Mehta-Lee, Ghislaine C. Echevarria, Sara G. Brubaker, Yasaman Yaghoubian, Sara E. Long, Cara D. Dolin

    Objective Both psychosocial stress and gestational weight gain are independently associated with adverse maternal and fetal outcomes. Studies of the association between psychosocial stress and gestational weight gain (GWG) have yielded mixed results. The objective of this study was to evaluate the association between psychosocial stress and GWG in a large population-based cohort. Methods Data from the nationally representative Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 7 questionnaire 2012–2015 was utilized. Maternal psychosocial stress was assessed through response to questions designed to examine four domains of psychosocial stress (i.e., traumatic, financial, emotional, partner-related) three months prior to or during pregnancy. GWG was categorized using pre-pregnancy BMI and total GWG into inadequate, adequate, or excessive according to the Institute of Medicine’s GWG guidelines. Multinomial logistic regression was used to evaluate the association between psychosocial stressors and adequacy of GWG. Analyses took into account complex survey design. Results All respondents who delivered ≥ 37 weeks gestation with GWG information available were included in the analysis (n = 119,183). After adjusting for confounders, patients who reported financial stress were more likely to experience excessive versus adequate GWG (RRR 1.09 [95%CI: 1.02–1.17]). Exposure to any of the stressor groups did not significantly increase the risk of inadequate GWG. Conclusions This large, population-based study revealed that among pregnant people in the US, exposure to financial stress is associated with higher risk of excessive GWG. Understanding the role stress plays in GWG will help to inform initiatives targeting this important aspect of prenatal care.

  • Risk Assessment Model for Postpartum Venous Thromboembolism Prevention in Patients with Systemic Lupus Erythematosus

    by Myah M. Griffin, Alexis Engel, Shilpi S. Mehta-Lee, Julie Nusbaum, Michael Golpanian, Peter Izmirly, H. Michael Belmont, Jill P. Buyon

    Objective This article assesses the application of the Royal College of Obstetricians and Gynaecologists (RCOG) venous thromboembolism (VTE) risk model on a cohort of postpartum patients with a history of systemic lupus erythematosus (SLE). Study Design This is a secondary analysis of an ongoing patient registry of women with SLE from 2016 to 2022. There were 49 SLE patients with 55 pregnancies using the Definitions of Remission in SLE (DORIS) criteria to determine SLE disease activity. RCOG risk assessment model scoring was calculated for each patient prior to and after delivery. The primary outcome was the qualification of “active SLE” by standard rheumatologic criteria and assessment of recommendations for VTE prophylaxis based on RCOG VTE risk assessment scoring. Data were analyzed using Fisher's exact test, chi-square test, and Mann–Whitney U test with significance defined as p < 0.05. Results In the study cohort, 34 pregnancies (61.8%) were in DORIS remission at delivery. Twenty-one pregnancies (38.2%) were not and scored 3 points on the RCOG VTE risk model. Of these pregnancies, only 19% (n = 4) were recommended for VTE prophylaxis by the obstetrical provider despite RCOG score ≥3. Only 35.7% (n = 5) of pregnancies in DORIS remission, but with 3 points for non-SLE-related VTE risk factors (n = 14), were recommended for VTE prophylaxis. Of the 20 pregnancies in remission with an RCOG score < 3 after assessing all risk factors, 15% (n = 3) were nevertheless recommended for VTE prophylaxis. No patients had a postpartum VTE regardless of therapy. Conclusion These data reveal a need to improve upon providing postpartum VTE prophylaxis to SLE patients not in remission while also recognizing a diagnosis of SLE alone should not equate with active disease. Moreover, SLE patients in remission may still warrant VTE prophylaxis if other non-SLE-related risk factors are present. Key Points


  • Variability and correlations of synthetic chemicals in urine from a New York City-based cohort of pregnant women

    by Abigail Gaylord, Kurunthachalam Kannan, Mathusa Lakuleswaran, Hongkai Zhu, Akhgar Ghassabian, Melanie H. Jacobson, Sara Long, Hongxiu Liu, Yelena Afanasyeva, Linda G. Kahn, et al.